Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors

OBJECTIVES: MEMOGAL study (NCT04319081) is aimed at evaluating changes in cognitive function in patients treated with PCSK9 inhibitors (PCSK9i). This is the first analysis: (1) discussion about the role of the Hospital Pharmacists during the pandemic, and also the assessment of the impact of COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Seijas-Amigo, Jose, Gayoso-Rey, Mónica, Mauriz-Montero, María José, Suarez-Artime, Pedro, Casas-Martinez, Antonia, Dominguez-Guerra, María, Gonzalez-Freire, Lara, Estany-Gestal, Ana, Codero-Fort, Alberto, Rodriguez-Mañero, Moisés, Gonzalez-Juanatey, Jose Ramón
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Arteriosclerosis. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411146/
http://dx.doi.org/10.1016/j.artere.2022.08.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411146/
http://dx.doi.org/10.1016/j.artere.2022.08.002

Ejemplares similares